Todd E DeFor (Todd E Defor)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Extracorporeal Membrane Oxygenation

Top Venues

Bone marrow transplantation

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Cichocki, Bin Zhang, Cheng-Ying Wu, Emily Chiu, Abderrahman Day, Roderick O'Connor, Dima Yackoubov, Ronit Simantov, David H McKenna, Qing Cao, Todd E DeFor, Murali Janakiram, Rose Wangen, Zuzan Cayci, Nathaniel W Snyder, Akhilesh Kumar, Bartosz J Grzywacz, Justin H Hwang, Yona Geffen, Jeffrey S Miller, Joseph E Maakaron, Veronika Bachanova
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma. Science translational medicine 15 (705) (2023)
Najla El Jurdi, Grigori Okoev, Todd E DeFor, Shernan G Holtan, Brian C Betts, Bruce R Blazar, Claudio G Brunstein, Margaret L MacMillan, Daniel J Weisdorf, Mukta Arora
Predictors and outcomes of flares in chronic graft-versus-host disease. Bone marrow transplantation 57 (5) (2022)
Phuong Vo, Ted A Gooley, Paul A Carpenter, Mohamed Lotfy Sorror, Margaret L MacMillan, Todd E DeFor, Paul J Martin
Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood advances 6 (11) (2022)
Divya Bhargava, Cathleen Drilling, Todd E DeFor, Claudio G Brunstein, Bharat Thygarajan, Najla El Jurdi, Shernan G Holtan, Armin Rashidi, Erica Warlick, Vidhyalakshmi Ramesh, John Rogosheske, Mukta Arora, Smita Bhatia, Daniel J Weisdorf
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients. Bone marrow transplantation 57 (7) (2022)
Sarah Cooley, Fiona He, Veronika Bachanova, Gregory M Vercellotti, Todd E DeFor, Julie M Curtsinger, Paul Robertson, Bartosz Grzywacz, Kevin C Conlon, Thomas A Waldmann, David H McKenna, Bruce R Blazar, Daniel J Weisdorf, Jeffrey S Miller
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia. Blood advances 3 (13) (2020)